The ALBA Project (Antigens for Liver and Breast Anticancer vaccines) proposes the development of cancer vaccines based on tumor microproteins (MPs) and their clinical implementation. It also aims to establish in Navarra cutting‑edge technology in genomics, bioinformatics, mathematics, immunology, molecular biology and chemistry, transfer the results to the clinic and the business sector, and equip Navarra with unique strategies for the treatment of cancer and future pandemics.
Call: Grants for carrying out strategic R&D projects in 2024–2027 from the Government of Navarra
Type of action: GEMA VIII. Personalised medicine and advanced therapies.
Proposal number: 0011-1411-2024-000047
Proposal acronym: ALBA
Duration (months): 30
Proposal title: Antigens for Liver and Breast Anticancer vaccines: Identification of microproteins (MPs) to generate cancer vaccines
Total funding: 1.701.960,47 €
07/01/2024 - 12/31/2026
